TRIAZOLAM

N/A

Manufactured by Pharmacia & Upjohn Company LLC

15,429 FDA adverse event reports analyzed

Last updated: 2026-04-14

About TRIAZOLAM

TRIAZOLAM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Pharmacia & Upjohn Company LLC. The most commonly reported adverse reactions for TRIAZOLAM include DRUG ABUSE, DRUG INEFFECTIVE, SOPOR, NAUSEA, OVERDOSE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TRIAZOLAM.

Top Adverse Reactions

DRUG ABUSE519 reports
DRUG INEFFECTIVE450 reports
SOPOR402 reports
NAUSEA352 reports
OVERDOSE351 reports
FALL315 reports
INSOMNIA303 reports
PYREXIA302 reports
SUICIDE ATTEMPT302 reports
DIARRHOEA290 reports
DIZZINESS282 reports
SOMNOLENCE280 reports
MALAISE268 reports
HEADACHE261 reports
LOSS OF CONSCIOUSNESS260 reports
INTENTIONAL OVERDOSE255 reports
FATIGUE251 reports
DRUG INTERACTION250 reports
VOMITING237 reports
TOXICITY TO VARIOUS AGENTS236 reports
DYSPNOEA232 reports
PAIN227 reports
ASTHENIA225 reports
COMPLETED SUICIDE222 reports
PNEUMONIA207 reports
ANXIETY203 reports
DEATH201 reports
OFF LABEL USE195 reports
DEPRESSION193 reports
DECREASED APPETITE186 reports
CONFUSIONAL STATE180 reports
DEPRESSED LEVEL OF CONSCIOUSNESS169 reports
INTENTIONAL SELF INJURY164 reports
COMA157 reports
ANAEMIA147 reports
HYPOTENSION147 reports
CONDITION AGGRAVATED144 reports
RASH139 reports
DEHYDRATION138 reports
HEPATIC FUNCTION ABNORMAL133 reports
ABDOMINAL PAIN128 reports
FEELING ABNORMAL124 reports
CONSTIPATION123 reports
TREMOR123 reports
HYPERTENSION121 reports
INTERSTITIAL LUNG DISEASE120 reports
ALTERED STATE OF CONSCIOUSNESS118 reports
ARTHRALGIA118 reports
GAIT DISTURBANCE117 reports
WEIGHT DECREASED117 reports
ABDOMINAL PAIN UPPER116 reports
BLOOD CREATINE PHOSPHOKINASE INCREASED116 reports
BACK PAIN114 reports
ASPARTATE AMINOTRANSFERASE INCREASED113 reports
DRUG DEPENDENCE113 reports
SYNCOPE113 reports
RHABDOMYOLYSIS112 reports
ALANINE AMINOTRANSFERASE INCREASED111 reports
RENAL IMPAIRMENT108 reports
SUICIDAL IDEATION108 reports
PAIN IN EXTREMITY105 reports
RENAL FAILURE105 reports
PRURITUS103 reports
WEIGHT INCREASED102 reports
PLATELET COUNT DECREASED101 reports
DELIRIUM93 reports
ACUTE KIDNEY INJURY92 reports
CHEST PAIN92 reports
DRUG HYPERSENSITIVITY92 reports
BLOOD PRESSURE INCREASED90 reports
WHITE BLOOD CELL COUNT DECREASED90 reports
AMNESIA87 reports
MEMORY IMPAIRMENT87 reports
CARDIAC FAILURE86 reports
HYPOAESTHESIA86 reports
OEDEMA PERIPHERAL86 reports
AGITATION84 reports
LIVER DISORDER84 reports
HALLUCINATION83 reports
INTENTIONAL PRODUCT MISUSE83 reports
URINARY TRACT INFECTION83 reports
ERYTHEMA82 reports
HYPONATRAEMIA82 reports
BLOOD PRESSURE DECREASED80 reports
BRADYCARDIA78 reports
HYPERHIDROSIS77 reports
NASOPHARYNGITIS77 reports
BLOOD CREATININE INCREASED76 reports
HYPOGLYCAEMIA76 reports
HAEMOGLOBIN DECREASED75 reports
ELECTROCARDIOGRAM QT PROLONGED73 reports
ROAD TRAFFIC ACCIDENT73 reports
RESPIRATORY FAILURE72 reports
PALPITATIONS71 reports
CHRONIC KIDNEY DISEASE70 reports
MUSCLE SPASMS70 reports
TACHYCARDIA70 reports
RENAL FAILURE ACUTE69 reports
ATRIAL FIBRILLATION68 reports
DYSARTHRIA68 reports

Report Outcomes

Out of 8,521 classified reports for TRIAZOLAM:

Serious 85.5%Non-Serious 14.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female4,621 (58.0%)
Male3,311 (41.6%)
Unknown30 (0.4%)

Reports by Age

Age 66151 reports
Age 70147 reports
Age 72146 reports
Age 73144 reports
Age 67143 reports
Age 80142 reports
Age 58138 reports
Age 68137 reports
Age 71134 reports
Age 77134 reports
Age 75131 reports
Age 82129 reports
Age 65128 reports
Age 74125 reports
Age 78125 reports
Age 60121 reports
Age 55119 reports
Age 64119 reports
Age 79115 reports
Age 69114 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with TRIAZOLAM?

This profile reflects 15,429 FDA FAERS reports that mention TRIAZOLAM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for TRIAZOLAM?

Frequently reported terms in FAERS include DRUG ABUSE, DRUG INEFFECTIVE, SOPOR, NAUSEA, OVERDOSE, FALL. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures TRIAZOLAM?

Labeling and FAERS entries often list Pharmacia & Upjohn Company LLC in connection with TRIAZOLAM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.